
1. j immunol. 2013 apr 1;190(7):3732-9. doi: 10.4049/jimmunol.1202964. epub 2013 mar
1.

reversion somatic mutations respiratory syncytial virus-specific human 
monoclonal antibody fab19 reveal direct relationship association rate
and neutralizing potency.

bates jt(1), keefer cj, utley tj, correia be, schief wr, crowe je jr.

author information: 
(1)department pediatrics, vanderbilt university medical center, nashville, tn 
37232, usa.

the role affinity determining neutralizing potency mabs directed against
viruses well understood. investigated kinetic, structural, and
functional advantage conferred individual naturally occurring somatic
mutations ab h chain v region fab19, well-described neutralizing
human mab directed respiratory syncytial virus. comparison the
affinity-matured ab fab19 recombinant fab19 abs variants
containing reverted amino acids inferred unmutated ancestor sequence
revealed molecular basis affinity maturation ab. enhanced binding
was achieved mutations third h chain cdr (hcdr3) conferred 
markedly faster on-rate desirable increase antiviral neutralizing
activity. contrast, somatic mutations hcdr1 hcdr2 regions 
not significantly enhance ag binding antiviral activity. observed direct 
relationship measured association rate (kon) f protein and
antiviral activity. modeling studies structure ag-ab complex
suggested hcdr3 loop interacts antigenic site surface loop 
respiratory syncytial virus f protein, previously shown contain epitope
for ab experimentation. studies define direct relationship of
affinity neutralizing activity viral glycoprotein-specific human mab.

doi: 10.4049/jimmunol.1202964 
pmcid: pmc3608519
pmid: 23455501  [indexed medline]

